TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33346789

Group type: EXPERIMENTAL
Intervention: 25 mg/kg/day cannabidiol (CBD25)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 50 mg/kg/day cannabidiol (CBD50)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 35473492

Group type: EXPERIMENTAL
Intervention: PWP-GT model with stratification by clusters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PWP-TT model with stratification by clusters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PWP-GT model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AG model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intervention condition
Number of subjects: 0
Study: 34330461

Group type: EXPERIMENTAL
Intervention: Diet + Physical Activity (PA)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control
Number of subjects: 46
Study: 32023931

Group type: EXPERIMENTAL
Intervention: Pan-fried (PF) beef steak sandwich
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sous-vide (SV) beef steak sandwich
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both cooking methods (PF and SV)
Number of subjects: 12
Study: 34167918

Group type: EXPERIMENTAL
Intervention: 1-mA stimulation protocol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2-mA stimulation protocol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study: 36262979

Group type: EXPERIMENTAL
Intervention: Nursing humanistic care intervention (experimental group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 110
Study: 33836651

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 33202147

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: CPAPflex
Number of subjects: 317
Study: 32060880

Group type: EXPERIMENTAL
Intervention: Personalized Normative Feedback (PNF) intervention
Number of subjects: 760

Group type: COMPARATOR
Intervention: No information (Control)
Number of subjects: 760
Study: 33338269

Group type: EXPERIMENTAL
Intervention: Atrasentan 0.75 mg/day
Number of subjects: 3668

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3668
Study: 32517390

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve pulsed radiofrequency (PRF) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Suprascapular nerve block (NB) with lidocaine
Number of subjects: 30
Study: 35598122

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) + Pyridoxamine di-hydrochloride (NP) (300mg NAC + 50mg pyridoxamine di-hydrochloride)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) + Taurine (NT) (500 mg Taurine + 150 mg NAC)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 69
Study: 33383999

Group type: EXPERIMENTAL
Intervention: Dry needling, manual therapy, and exercise
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham dry needling, manual therapy, and exercise
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both groups (Dry needling and Sham)
Number of subjects: 77
Study: 35104607

Group type: EXPERIMENTAL
Intervention: Anodal high-definition transcranial direct current stimulation (HD-tDCS) administered to the right inferior frontal gyrus (rIFG) for 5 consecutive days, twice a day.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham HD-tDCS administered to the right inferior frontal gyrus (rIFG) for 5 consecutive days, twice a day.
Number of subjects: 40
Study: 34525239

Group type: EXPERIMENTAL
Intervention: Single-use negative pressure wound therapy (s-NPWT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Traditional negative pressure wound therapy (t-NPWT)
Number of subjects: 95
Study: 35458108

Group type: EXPERIMENTAL
Intervention: DGA + POTATO (17.5 g/day resistant starch)
Number of subjects: 27

Group type: COMPARATOR
Intervention: DGA + BAGEL (0 g/day resistant starch)
Number of subjects: 27
Study: 34464517

Group type: EXPERIMENTAL
Intervention: BAY 1193397 (single oral doses of 0.5-50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BAY 1193397 (single doses of 1 and 10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BAY 1193397 (multiple doses of 2 and 5 mg twice daily and 10 and 20 mg once daily for 9 consecutive days)
Number of subjects: 0
Study: 32277343

Group type: EXPERIMENTAL
Intervention: Treat-and-extend protocol with moderate extensions (T&Em)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Treat-and-extend protocol with rapid extensions (T&Er)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Both treatment groups
Number of subjects: 52
Study: 34275865

Group type: EXPERIMENTAL
Intervention: Conditional-incentive arm (US$50 plus US$0.20 incentive per client visiting mobile-outreach services)
Number of subjects: 7146

Group type: COMPARATOR
Intervention: Non-incentive arm (one-off US$50 remuneration per CBD)
Number of subjects: 7146

Group type: EXPERIMENTAL
Intervention: Conditional-incentive arm
Number of subjects: 7146

Group type: COMPARATOR
Intervention: Non-incentive arm
Number of subjects: 7146

Group type: EXPERIMENTAL
Intervention: HIVST clinics during distribution
Number of subjects: 7146

Group type: COMPARATOR
Intervention: Non-HIVST clinics
Number of subjects: 7146
Study: 35871702

Group type: EXPERIMENTAL
Intervention: 3% potassium nitrate gel (UltraEZ)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBM) with a low-level infrared laser (100 mW, spot size of 0.028 cm2, dose of 1 J per point)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 3% potassium nitrate gel + PBM
Number of subjects: 54
Study: 32075440

Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: IV ketorolac
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Combination of IV acetaminophen and IV ketorolac
Number of subjects: 44
Study: 35820741

Group type: EXPERIMENTAL
Intervention: Heat therapy with natural thermal mineral water (38°C)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Thermoneutral water baths (30°C-32°C)
Number of subjects: 130
Study: 34570798

Group type: EXPERIMENTAL
Intervention: Video of Trump endorsing the vaccine
Number of subjects: 387

Group type: COMPARATOR
Intervention: Public health expert excerpt
Number of subjects: 387
Study: 35877092

Group type: EXPERIMENTAL
Intervention: Comprehensive telehealth intervention (n = 101)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Telemonitoring and care coordination (n = 99)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Comprehensive telehealth intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Telemonitoring and care coordination
Number of subjects: 200
Study: 32067288

Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (50 mg daily for 4 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 36113914

Group type: EXPERIMENTAL
Intervention: Non-judgmental mirror gazing task
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Judgmental mirror gazing task
Number of subjects: 125
Study: 33792743

Group type: EXPERIMENTAL
Intervention: Baseline PSA testing in study arm A
Number of subjects: 23301
Study: 32902102

Group type: EXPERIMENTAL
Intervention: Gold alloy abutments
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Titanium, titanium-base, and zirconia abutments
Number of subjects: 17

Group type: COMPARATOR
Intervention: All abutment materials
Number of subjects: 17
Study: 36278773

Group type: EXPERIMENTAL
Intervention: AT plus WC (group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AT plus WC plus CsA 0.05% (group B)
Number of subjects: 40
Study: 33027815

Group type: EXPERIMENTAL
Intervention: RO4929097
Number of subjects: 47
Study: 33971278

Group type: EXPERIMENTAL
Intervention: 50,000 IU bolus dose of vitamin D plus 1000 IU daily supplement for six weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: 1000 IU daily supplement alone
Number of subjects: 22
Study: 616781077

Group type: EXPERIMENTAL
Intervention: Surgical cricothyrotomy technique
Number of subjects: 11

Group type: COMPARATOR
Intervention: Portex Cricothyrotomy Kit
Number of subjects: 11

Group type: COMPARATOR
Intervention: Melker Cricothyrotomy kit
Number of subjects: 11
Study: 34321042

Group type: EXPERIMENTAL
Intervention: Technology-supported sitting balance therapy (12 sessions of 50 min over four weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 30
Study: 33258933

Group type: EXPERIMENTAL
Intervention: Geographic information system-based geosurvey and field mapping system
Number of subjects: 25221
Study: 35924472

Group type: EXPERIMENTAL
Intervention: Mini-electrode (ME) catheter
Number of subjects: 136
Study: 32887732

Group type: EXPERIMENTAL
Intervention: Screening with flexible sigmoidoscopy (with a repeat screening at 3 or 5 years)
Number of subjects: 2359

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2359

Group type: EXPERIMENTAL
Intervention: Gradient-boosted model prediction
Number of subjects: 2359
Study: 32815439

Group type: COMPARATOR
Intervention: Oral semaglutide
Number of subjects: 0
Study: 34878659

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg IV every 3 weeks for ≤2 years)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Paclitaxel (80 mg/m2 IV every week)
Number of subjects: 94
Study: 33915251

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel (100 mg/m2 on days 1, 8, and 15 of a 21-day cycle)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m2 on day 1)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel (100 mg/m2)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m2)
Number of subjects: 503
Study: 34986500

Group type: EXPERIMENTAL
Intervention: lavender, eucalyptus and tangerine essential oils
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: lavender, eucalyptus, tangerine and melaleuca essential oils
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 34118964

Group type: COMPARATOR
Intervention: Urban schools
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Rural schools
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Microbial species
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Human endocrine and metabolic disease pathways
Number of subjects: 1332
Study: 34542079

Group type: EXPERIMENTAL
Intervention: Mindfulness-based training (MBT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Cognitive rehabilitation therapy (CRT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 76
Study: 36094821

Group type: EXPERIMENTAL
Intervention: Norepinephrine (NE) infiltration during PCNL
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (saline) infiltration during PCNL
Number of subjects: 140
Study: 36184258

Group type: EXPERIMENTAL
Intervention: 80 mg Atomoxetine (ATO) + 5 mg Oxybutynin (OXY)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No medication (control)
Number of subjects: 17
Study: 36384573

Group type: COMPARATOR
Intervention: Whole-breast irradiation (WBI) and regional nodal irradiation (RNI)/post-mastectomy radiotherapy (PMRT)
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Whole-breast irradiation (WBI) alone/no PMRT
Number of subjects: 1106
Study: 36440985

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg orally 2 hours before surgery
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg orally
Number of subjects: 55
Study: 34701225

Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3D Conformal Radiation Therapy (3DCRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 0
Study: 33999650

Group type: EXPERIMENTAL
Intervention: HFrEF-PRS (plasma proteomic risk score) derived from 681 patients in the derivation cohort.
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: HFrEF-PRS validated in 336 patients.
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: HFrEF-PRS adjusted for clinical score and NT-proBNP.
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: HFrEF-PRS metrics of risk stratification.
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: HFrEF-PRS associated with cardiovascular death and HF phenotypes.
Number of subjects: 1017
Study: 35429005

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive therapy (I‐CT) for 10 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Participants who understood the cognitive model
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Reductions in negative appraisals
Number of subjects: 19
Study: 34199645

Group type: EXPERIMENTAL
Intervention: High LCn3 diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High LCn3 & PP diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High PP diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low LCn3 & PP diet
Number of subjects: 0
Study: 35964063

Group type: COMPARATOR
Intervention: Family-based Improvement for Health Literacy (FAMILY) intervention, which includes health literacy education interventions such as project preparation, core group building, promotion within family branch, and competition between family branches.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contracted Family Doctor Services as control measure.
Number of subjects: 0
Study: 34596672

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) training for pediatricians
Number of subjects: 164

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 164
Study: 32521976

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation (ONS) 2092 kJ/day, whole protein enteral nutrition for 90 days after discharge
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (dietary guidance only)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation (ONS)
Number of subjects: 90
Study: 36255262

Group type: EXPERIMENTAL
Intervention: Sodium polynucleotide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Classic hyaluronic acid
Number of subjects: 90

Group type: COMPARATOR
Intervention: Crosslinked hyaluronic acid
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (including polynucleotide, classic hyaluronic acid, and crosslinked hyaluronic acid)
Number of subjects: 90
Study: 35761370

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg stat then 400 mg weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 0
Study: 33213194

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (FC)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: COMPARATOR
Intervention: Cohort (FibTEM-MCF ≥7 mm)
Number of subjects: 111
Study: 33812327

Group type: EXPERIMENTAL
Intervention: NSAID + magnesium (400 mg etodolac twice a day with 365 mg oral magnesium supplementation)
Number of subjects: 240

Group type: COMPARATOR
Intervention: NSAID alone (400 mg etodolac twice a day)
Number of subjects: 240

Group type: COMPARATOR
Intervention: NSAID + paracetamol (400 mg etodolac twice a day with 500 mg paracetamol twice a day)
Number of subjects: 240
Study: 32179149

Group type: EXPERIMENTAL
Intervention: CMS loading dose (LD group) of 4 mg CBA/kg/dose
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard initial dose (NLD group) of 2.5 mg (12-h interval) or 1.7 mg (8-h interval) of CBA/kg/dose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups monitored for acute kidney injury (AKI)
Number of subjects: 20
Study: 33054505

Group type: EXPERIMENTAL
Intervention: POAG with PLWDs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: POAG without PLWDs
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: All patients without PLWDs
Number of subjects: 40
Study: 32868437

Group type: EXPERIMENTAL
Intervention: Serological measures of transmission based on antibody response to S. mansoni soluble egg antigen (SEA)
Number of subjects: 3663

Group type: EXPERIMENTAL
Intervention: Serological measures of transmission
Number of subjects: 3663
Study: 34831884

Group type: EXPERIMENTAL
Intervention: Multilevel multicomponent (MLMC) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to sub-components of the intervention
Number of subjects: 0
Study: 33506411

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 5 mg/kg of Se from SeGlu
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 0.3 mg/kg of Se from sodium selenite (SS)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Basal diet alone (control group)
Number of subjects: 360
Study: 35638864

Group type: EXPERIMENTAL
Intervention: Nasal irrigation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nasal spray
Number of subjects: 38
Study: 33159220

Group type: EXPERIMENTAL
Intervention: Novel AML decision aid
Number of subjects: 20
Study: 32514756

Group type: EXPERIMENTAL
Intervention: 30 mg/day of elemental zinc for three months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 60
Study: 35609978

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 33068032

Group type: EXPERIMENTAL
Intervention: Preclinical safety studies (PCSSs) included in Investigator's Brochures (IBs)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Investigator's Brochures (IBs) reporting patterns
Number of subjects: 46
Study: 35338094

Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Neurosurgical clipping
Number of subjects: 130
Study: 33231752

Group type: EXPERIMENTAL
Intervention: Symphyseal chin grafts
Number of subjects: 14

Group type: COMPARATOR
Intervention: Retromolar grafts
Number of subjects: 14
Study: 35838773

Group type: EXPERIMENTAL
Intervention: Web-based smoking cessation decision aid with explicit value clarification method and computer-tailored advice
Number of subjects: 2375
Study: 34154634

Group type: EXPERIMENTAL
Intervention: Supervised training of activities of daily living (ADL), resistance, and stability, twice a week for 1 hour per session
Number of subjects: 57

Group type: COMPARATOR
Intervention: Daily home-based exercise representing regular outpatient care
Number of subjects: 57
Study: 35383128

Group type: EXPERIMENTAL
Intervention: Clinical peer review in intervention hospitals
Number of subjects: 25074

Group type: COMPARATOR
Intervention: Control group (no clinical peer review)
Number of subjects: 25074
Study: 34028460

Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate + rhinophototherapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intranasal beclomethasone dipropionate
Number of subjects: 75
Study: 32948120

Group type: EXPERIMENTAL
Intervention: Singing group intervention (34 bi-weekly sessions, 2 hours each for 4 months)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Regular activities proposed by the institution (Control group)
Number of subjects: 140
Study: 36182594

Group type: EXPERIMENTAL
Intervention: EZ10/AS10 (ezetimibe/atorvastatin 10/10 mg FDC)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: EZ10/AS20 (ezetimibe/atorvastatin 10/20 mg FDC)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg (AS20)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg (AS40)
Number of subjects: 454
Study: 34232510

Group type: EXPERIMENTAL
Intervention: Semipermeable glove liners made of Sympatex (SYM)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Cotton glove liners (COT)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both glove liners (SYM and COT)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Previously used protective gloves (PUGs)
Number of subjects: 161
Study: 32645934

Group type: EXPERIMENTAL
Intervention: WHEY-ALL (whey protein, 3.1 µg B12/day)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: LITW (light resistance training with whey protein)
Number of subjects: 167

Group type: COMPARATOR
Intervention: COLL (collagen, 1.3 µg B12/day)
Number of subjects: 167

Group type: COMPARATOR
Intervention: CARB (maltodextrin, 0.3 µg B12/day)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: HRTW (heavy resistance training with whey protein)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: WHEY (no training with whey protein)
Number of subjects: 167
Study: 35931975

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Regular medical care (Control)
Number of subjects: 155
Study: 32608934

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 36336005

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 1142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1142
Study: 34426397

Group type: EXPERIMENTAL
Intervention: Oral ondansetron (0.1 mg/kg)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 194
Study: 32810504

Group type: EXPERIMENTAL
Intervention: Inhaled diesel exhaust (DE) at 200 μg/m3
Number of subjects: 19

Group type: COMPARATOR
Intervention: Antioxidant pretreatment (1000 mg ascorbate for 7 days and 1200 mg N-acetylcysteine 1 day prior to exposure)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Filtered air exposure
Number of subjects: 19
Study: 36238226

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 326
Study: 33487254

Group type: EXPERIMENTAL
Intervention: Low-fat plant-based dietary intervention for 16 weeks
Number of subjects: 244
Study: 34231653

Group type: COMPARATOR
Intervention: Resistance training using weightlifting machines (gym group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Resistance training using free weights and elastic bands (freew group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both RT groups (gym and freew)
Number of subjects: 74